These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2786964)

  • 21. The true cost of a free AIDS vaccine.
    Science; 1993 Aug; 261(5125):1107. PubMed ID: 8356442
    [No Abstract]   [Full Text] [Related]  

  • 22. HHS fumbles ball on AIDS vaccine trial.
    Science; 1993 Jul; 261(5118):151. PubMed ID: 8327883
    [No Abstract]   [Full Text] [Related]  

  • 23. Using a novel cellular platform to optimize CRISPR/CAS9 technology for the gene therapy of AIDS.
    He J; Zhang T; Fu X
    Protein Cell; 2017 Nov; 8(11):848-852. PubMed ID: 28822100
    [No Abstract]   [Full Text] [Related]  

  • 24. Highlights from the University of California San Diego Center for AIDS Research.
    Wong-Staal F
    AIDS Res Hum Retroviruses; 1997 Jan; 13(2):117-20. PubMed ID: 9007196
    [No Abstract]   [Full Text] [Related]  

  • 25. [AIDS: initial results of combination therapy. AIDS and ARC--alternating or intermittent medication].
    Mahler W
    Fortschr Med; 1991 Jan; 109(1):52. PubMed ID: 1850712
    [No Abstract]   [Full Text] [Related]  

  • 26. R-interferon alpha A and suramin sodium in the treatment of AIDS and ARC cases.
    Raise E; Gritti FM; Bonazzi L; Monti M; Grillo A; Savoia M; Gambetti M; Pulsatelli L; Casertano MG; Di Figlia C
    J Exp Pathol; 1987; 3(4):737-43. PubMed ID: 3454811
    [No Abstract]   [Full Text] [Related]  

  • 27. [Possibilities and perspectives of genetic engineering in management of genetic diseases, neoplasms and AIDS].
    Nowak J
    Pol Arch Med Wewn; 1993 May; 89(5):418-23. PubMed ID: 8367377
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of recombinant soluble CD4 on human peripheral blood lymphocyte responses in vitro.
    Liu MA; Liu T
    J Clin Invest; 1988 Dec; 82(6):2176-80. PubMed ID: 3264292
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of advanced, progressive epidemic Kaposi's sarcoma (EKS): a phase-II study.
    Mitrou PS; Fischer C; Huhn D; Rasokat H; Ring J; Bergmann L
    Onkologie; 1988 Feb; 11(1):61-2. PubMed ID: 2452394
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A molecular genetic intervention for AIDS--effects of a transdominant negative form of Rev.
    Nabel GJ; Fox BA; Post L; Thompson CB; Woffendin C
    Hum Gene Ther; 1994 Jan; 5(1):79-92. PubMed ID: 8155773
    [No Abstract]   [Full Text] [Related]  

  • 31. Opportunities "opening up" for gene therapy.
    Vanchieri C
    J Natl Cancer Inst; 1993 Jan; 85(2):90-1. PubMed ID: 8418310
    [No Abstract]   [Full Text] [Related]  

  • 32. Scientific, logistical, and ethical issues related to creation of a stem cell repository for use in experimental trials of gene therapy for AIDS.
    Fraser JK; Sugarman J; McCurdy PR; Martin NL; Ammann AJ
    AIDS Res Hum Retroviruses; 1997 Jul; 13(11):905-7. PubMed ID: 9223405
    [No Abstract]   [Full Text] [Related]  

  • 33. Soluble CD4: a new antiviral treatment for AIDS.
    Glaser V
    N Y State J Med; 1990 May; 90(5):280-1. PubMed ID: 2348952
    [No Abstract]   [Full Text] [Related]  

  • 34. Treatment of AIDS-related Kaposi's sarcoma with recombinant gamma-interferon.
    Ganser A; Brücher W; Brodt HR; Busch W; Brandhorst I; Helm EB; Hoelzer D
    Onkologie; 1986 Jun; 9(3):163-6. PubMed ID: 3018647
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Granulocyte macrophage colony stimulating factor (GM-CSF) in AIDS.
    Scadden DT
    Prog Clin Biol Res; 1990; 338():163-76. PubMed ID: 2189138
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gene therapy progress and prospects: novel gene therapy approaches for AIDS.
    Wolkowicz R; Nolan GP
    Gene Ther; 2005 Mar; 12(6):467-76. PubMed ID: 15703764
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of recombinant human granulocyte-macrophage colony-stimulating factor on myelopoiesis in the acquired immunodeficiency syndrome.
    Groopman JE; Mitsuyasu RT; DeLeo MJ; Oette DH; Golde DW
    N Engl J Med; 1987 Sep; 317(10):593-8. PubMed ID: 3497344
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD4+ lymphocyte function with early human immunodeficiency virus infection.
    Gurley RJ; Ikeuchi K; Byrn RA; Anderson K; Groopman JE
    Proc Natl Acad Sci U S A; 1989 Mar; 86(6):1993-7. PubMed ID: 2564677
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of human immunodeficiency virus type 1 replication by regulated expression of a polymeric Tat activation response RNA decoy as a strategy for gene therapy in AIDS.
    Lisziewicz J; Sun D; Smythe J; Lusso P; Lori F; Louie A; Markham P; Rossi J; Reitz M; Gallo RC
    Proc Natl Acad Sci U S A; 1993 Sep; 90(17):8000-4. PubMed ID: 8367455
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Retroviral vectors expressing soluble CD4: a potential gene therapy for AIDS.
    Morgan RA; Looney DJ; Muenchau DD; Wong-Staal F; Gallo RC; Anderson WF
    AIDS Res Hum Retroviruses; 1990 Feb; 6(2):183-91. PubMed ID: 2328156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.